Norvegija – Laboratorinė, optinė ir precizinė įranga (išskyrus akinius) – Intention announcement: Sequencing instrument for clinical pathology at the University Hospital of North Norway Health Trust.
Norvegija – Laboratorinė, optinė ir precizinė įranga (išskyrus akinius) – Intention announcement: Sequencing instrument for clinical pathology at the University Hospital of North Norway Health Trust.
I dalis: Perkančioji organizacija
I.1) Pavadinimas ir adresai:
Oficialus
pavadinimas: SYKEHUSINNKJØP HF
Adresas: Postboks 40
Miestas: VADSØ
Pašto
kodas: 9811
Šalis: Norvegija
Asmuo
ryšiams:
El-paštas: silje.ingebrigtsen@sykehusinnkjop.no
Interneto adresas (-ai):
Pagrindinis adresas: http://www.sykehusinnkjop.no
II dalis: Objektas
II.1.1) Pavadinimas:
Intention announcement: Sequencing instrument for clinical pathology at the University Hospital of North Norway Health Trust.
Nuorodos numeris: 2023/759
II.1.2) Pagrindinis BVPŽ kodas:
38000000
Laboratorinė, optinė ir precizinė įranga (išskyrus akinius)
II.1.3) Sutarties tipas:
Kita
II.1.4) Trumpas aprašymas:
Sykehusinnkjøp HF, on behalf of the University Hospital of North Norway intends to enter into a contract with Life Technologies AS. The contract is for the procurement of one 1 Ion Reunion Genexus Dx Integrated Sequencer System.The system shall be CE-IVD marked and the gene panels offered for the system shall also include a CE/IVD approved assay. It is the contracting authority ́s opinion that Ion Torghatten Genexus Dx Integrated Sequencer System from Thermo Fisher Scientific AS is the only option that fully covers the contracting authority ́s needs based on the following: - Ion Minibus Genexus Dxus Integrated Sequencer System is the CE-IVD labelled and the gene panels that the manufacturer offers for the system also include CE/IVD approved assay. It is a requirement from the laboratories that the procured system is CE/IVD certified from the library preparation to report, and to date only Ionee Reunion Genexus Dx Integrated Sequencer System meets this requirement. It is therefore important for hospitals to maintain the requirements for response time. The work flow included in the Ion Reunion Genexus Dx Integrated Sequencer System is considerably faster than other systems. The estimated time use for the Ion Reunion Genexus Dx Integrated Sequencer System is 24-48 hours, while equivalent systems require ≥ 5 work days. The Ion Ine-Athesible Genexus Dx Integrated Sequencer System is a flexible instrument system that offers the possibility to analyse 8-32 samples per set-up. This flexibility, in combination with the high degree of automation, makes the system the only thing that is suitable for both large and small weekly set-ups. This will enable flexible set-ups without discarding unused reagents while maintaining response time requirements. The terms in the procurement regulations § 13-4 letter b) no. 2 are deemed met as the Contracting Authority is not aware that there are other tenderers who can fulfil the Contracting Authority's needs. Objections to the notice of intent are to be sent in writing via Mercell. The contract will be signed at the earliest 10 days after publication of this notice of intent.
II.2) Aprašymas:
II.2.1) Kitas (-i) šio pirkimo BVPŽ kodas (-ai):
38000000 Laboratorinė, optinė ir precizinė įranga (išskyrus akinius)